Giordano, Claudia, and Marco Picardi. 2020. “Early Intensification With Bendamustine Supercharge Plus Brentuximab Vedotinfollowing Failure to Obtain Complete Metabolic Remission After Two Cycles of ABVD Inpatients Aged ≤60 Years With Classic Hodgkin Lymphoma. Comment on:‘Brentuximab-Vedotin and Bendamustine for Relapsed or Refractory Hodgkinlymphoma: The LYSA Real-World experience’”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2026.301273.